S. Robert Witherspoon, M.D.

  • Retina Institute of Texas, PA; Vitreous and Retina Diagnosis and Surgery: 
    • Associate Aug. 1, 2009 – July 31, 2011
    • Partner Aug. 1, 2011 – Present

  • Oregon Health and Science University/Casey Eye Institute and Devers Eye Institute, Portland, OR Fellowship in Vitreoretinal Surgery and Disease, 2007-2009
  • University of Texas-Southwestern/Parkland Memorial Hospital, Dallas, TX, Residency in Ophthalmology, 2004-2007
  • University of Texas-Southwestern/Parkland Memorial Hospital, Dallas, TX, Internship Internal Medicine, 2003-2004
  • Saint Louis University School of Medicine, St. Louis, MO, Doctorate of Medicine, Summa cum Laude 1999-2003
  • University of Missouri, Columbia, MO, Bachelor of Science, Magna cum Laude 1995-1999

  • USMLE Step 1: 2001
  • USMLE Step 2: 2002
  • USMLE Step 3: 2004
  • American Board of Ophthalmology: 2008

  • University of Texas-Southwestern Medical Center, Department of Ophthalmology, Outstanding Service Award for Exceptional Contribution and Dedication to the Ophthalmology Residency Program;  2012, 2013, 2014, 2015
  • Dallas Academy of Ophthalmology:
    • Chairperson 2016-2017
    • Vice-President 2015-2016
    • Program Chairperson 2014-2015
    • Secretary 2013-2014
  • University of Texas-Southwestern Alumni Day Research Award; First Place, 2007
  • University of Texas-Southwestern Alumni Day Research Award; Second Place, 2006
  • Summa cum Laude, Saint Louis University, 2003
  • Alpha Omega Alpha, Junior Year 2002-2003
  • Alpha Sigma Nu National Jesuit Honor Society, 2003
  • Saint Louis University Alumni Distinguished Student Award, 2003 (Awarded to a senior student of high moral character and scholastic achievement who has manifested service to patients, fellow students, and the School of Medicine)
  • Donald W. Bussmann Award, 2003 (Awarded to the medical student who demonstrates outstanding scholarship and performance on one’s surgical rotation)
  • AOA Student Research Forum Award; First Place Clinical Research Division, 2003
  • Surgery Student of the Year, Saint Louis University, 2002 (Voted on by the Surgery Department faculty to the top medical student performance on one’s surgery rotation)
  • Invited Speaker; White Coat Ceremony for class of 2006, 2002
  • Saint Louis University Alpha Omega Alpha Research Forum; first place, Clinical Research Division, 2001
  • Magna cum Laude, University of Missouri, 1999
  • Honors Scholar, University of Missouri, 1999

  • Medical Mission, Srikiran Institute of Ophthalmology; Kakinada, India 2006
  • Hope Medical Mission, Nicaragua 2003
  • O’Speaker; Greene County Medical Society Pre-Med Conference, 2002
  • Saint Louis University School of Medicine Admissions Committee Member and Tour Guide, 2002
  • HIV Educator for St. Louis high schools, 2001
  • Child Abuse Prevention, 1999-2001

  • Saint Louis University School of Medicine Admissions Committee member, 2000-2003
  • Saint Louis University School of Medicine Student Professional Conduct Council member, 2000-2002


  • Ali ZK, Whitson JT, Mootha VV, Witherspoon SR, Joseph JA, Joseph AM, Hynan LS, Cavanagh HD.  “Glaucoma in patients with corneal dystrophy .” Eye Contact Lens.  2011 Nov;37(6):332-6.
  • Chan-Kai BT, Yeh S, Weleber RG, Francis PJ, Adamus G, Witherspoon SR, Lauer AK.  “Electroretinographic findings in transplant chorioretinopathy.” Clin Ophthalmol.2010 Jul 30;4:777-83.
  • Yeh S, Forooghian F, Faia LJ, Weichel ED, Wong WT, Sen HN, Chan-Kai BT, Witherspoon SR, Lauer AK, Chew EY, Nussenblatt RB.  “Fundus autofluorescence changes in cytomegalovirus retinitis.” Retina. 2010 Jan:30(1):42-50.
  • Yeh S, Cebulla CM, Witherspoon SR, Emerson GG, Emerson MV, Suhler EB, Albini TA, Flaxel CJ.  “Management of fluocinolone implant dissociation during implant exchange.” Arch Ophthalmol. 2009 Sep;127(9):1218-21.
  • Dinges WL, Witherspoon SR, Itani KM, Garg A, Peterson DM.  “Blepharoptosis and external ophthalmoplegia associated with long-term antiretroviral therapy.” Clin Infect Dis. 2008 Sep 15;47(6):845-52
  • Witherspoon SR, Callanan D.  “Celiac disease presenting as a Xerophthalmic fundus.” Retina. 2008 Mar;28(3):525-6.
  • Charton, JW, Witherspoon SR, Jones FR, Marple B, Itani, K.  “Natural Killer/T-cell Lymphoma Masquerading as Orbital Cellulitis.” Ophthal Plast Reconstr Surg. 2008 Mar-Apr;24(2):143-5.
  • Witherspoon SR, Hogan RN, Petroll WM, Mootha VV, “Slitlamp, Confocal, and Light Microscopic Findings of Corneal Siderosis.” Cornea. 2007 Dec;26(10):1270-2
  • Witherspoon SR, Lauer AK.  “Ocular Injuries Caused by Conductive Energy Weapons” Conductive Energy Weapons, Ed: Kroll, M. Springer
  • Witherspoon CD, Morris R, Phillips R, Kuhn F, Nelson S, Witherspoon SR, “Severe combined anterior and posterior segment trauma.” Ocular Trauma: Principals and Practice, Ed: Kuhn F, Pieramici D. Thieme, New York, pp264-272, 2002.

  • Witherspoon SR, Dinges W, Itani K. “Ptosis and External Ophthalmoplegia Associated With Chronic Antiretroviral Therapy in Patients with HIV”.  ARVO, 2007
  • Williams P, Witherspoon SR, Callanan, D.  “The use of topical Nepafenac for the treatment of center involving diabetic macular edema”.  ARVO, 2007
  • Witherspoon SR, Jones FR, Marple B, Itani K. “Natural Killer/T-cell Lymphoma Masquerading as Orbital Cellulitis” 37th Annual ASOPRS Scientific Symposium in association with the American Academy of Ophthalmology annual meeting, 2006. 
  • Witherspoon SR, Blomquist PH, “The Changing Microbiologic Spectrum of Preseptal and Orbital Cellulitis: Emergence of Methicillin-Resistant Staphylococcus aureus”.  ARVO, 2006. 
  • Witherspoon SR, Hogan RN “Pathologic findings of choroidal melanoma in patients with HIV.” American Academy of Ophthalmology, 2005. 
  • McHenry JG, Witherspoon SR “Linezolid and optic neuropathy.” American Academy of Ophthalmology, 2005. 
  • Witherspoon SR, Kooner KS “Ocular associations found during diabetes screening examinations.” ARVO, 2005. 
  • Witherspoon CD, Morris R, Herring J, Kuhn F, Nelson S, Witherspoon SR, “Surgical management of traction maculopathies.”  Oslo Symposium in Ophthalmology, 2000. 

  • Witherspoon SR, Chan-Kai B, Weleber R, Watzke R, Lauer A.  “Atypical Acute Retinal Pigment Epitheliitis.” 2008 ASRS Annual Meeting (Fluoroscein Angiography Presentation). 
  • Witherspoon SR, Chan-Kai B, Flaxel C. “Shooting Baskets in the Wrong Hoop” 2008 Annual Retina Society Meeting (Fluoroscein Angiography Presentation). 
  • Chan-Kai B, Witherspoon SR, Weleber R, Lauer A. “Electroretinographic Findings and Autoretinal Antibodies in Transplant Chorioretinopathy.” 2008 ASRS Annual Meeting (Paper).
  • Yeh S, Forooghian F, Weichel ED, Wong WT, Faja LJ, Chan-Kai BT, Witherspoon SR, Lauer AK, Chew EY, Nussenblatt RB.  “Fundus autofluorescence imaging in the evaluation of cytomegalovirus retinitis.” 2008 ASRS Annual Meeting (Paper). 
  • Witherspoon SR, Blomquist PH. “Changing microbiologic spectrum of cellulitis.” Texas Ophthalmological Society Annual Meeting, 2006. 
  • Witherspoon, SR, Mootha, VV, “Procurement of amniotic membrane.” Srikiran Institute of Ophthalmology Continuing Medical Education.  Ocular Surface Disorders.  Kakinada, India 2006. 
  • Witherspoon SR. “The use of temporary keratoprosthesis for surgical management of advanced infectious endophthalmitis.”  Saint Louis University, Alpha Omega Alpha Research Competition 2001. 
  • Witherspoon SR, Witherspoon, CD, Morris R, Kuhn F. “Penetrating ocular nail gun injuries.” International Society for Ocular Trauma Symposium.  Montreal, 2000.
  • Co-Investigator.  The effect of genotype and environmental risk factors on treatment response to intravitreal Lucentis (ranibizumab) for neovascular AMD.  Investigator Sponsored.  Phase IV Clinical Trial.  Oregon Health & Science University, 2007-present. 
  • Co-Investigator, Phase II Multicenter, Randomized, Double-Masked, Placebo Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects With Age-Related Macular Degeneration.  Oregon Health & Science University, 2007-present.
  • Sub-Investigator.  Phase II Multicenter, Randomized study of the Efficacy of Ciliary Neurotrophic Factor delivered via Encapsulated Cell Technology (ECT) product for the treatment of visual loss associated with retinitis pigmentosa, 2007-present.


Copyright © 2002-2006 Retina Institute of Texas, PA
Web Hosting by OmicronWave Technologies, LLC